Bethany Sensenig - 17 Aug 2023 Form 3 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
17 Aug 2023
Net transactions value
$0
Form type
3
Filing time
21 Aug 2023, 17:01:09 UTC
Previous filing
21 Apr 2023
Next filing
26 Feb 2024

No securities are beneficially owned.